In vivorelease of non‐neuronal acetylcholine from the human skin as measured by dermal microdialysis: effect of botulinum toxin
- 29 January 2006
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 147 (2) , 183-187
- https://doi.org/10.1038/sj.bjp.0706451
Abstract
Acetylcholine is synthesized in the majority of non‐neuronal cells, for example in human skin. In the present experiments, thein vivorelease of acetylcholine was measured by dermal microdialysis. Two microdialysis membranes were inserted intradermally at the medial shank of volunteers. Physiological saline containing 1 μMneostigmine was perfused at a constant rate of 4 μl min−1and the effluent was collected in six subsequent 20 min periods. Acetylcholine was measured by high‐pressure liquid chromatography (HPLC) combined with bioreactors and electrochemical detection. Analysis of the effluent by HPLC showed an acetylcholine peak that disappeared, when the analytical column was packed with acetylcholine‐specific esterase, confirming the presence of acetylcholine. In the absence of neostigmine, 71±51 pmol acetylcholine (n=4) was found during a 120 min period. The amount increased to 183±43 pmol (n=34), when the perfusion medium contained 1 μMneostigmine. Injection of 100 MU botulinum toxin subcutaneously blocked sweating completely, but the release of acetylcholine was not affected (botulinum toxin treated skin: 116±70 pmol acetylcholine/120 min; untreated skin: 50±20 pmol;n=4). Quinine (1 mM), inhibitor of organic cation transporters, and carnitine (0.1 mM), substrate of the Na+‐dependent carnitine transporter OCTN2, tended to reduce acetylcholine release (by 40%, not significant). Our experiments demonstrate, for the first time, thein vivorelease of non‐neuronal acetylcholine in human skin. Organic cation transporters are not predominantly involved in the release of non‐neuronal acetylcholine from the human skin. British Journal of Pharmacology(2006)147, 183–187. doi:10.1038/sj.bjp.0706451Keywords
This publication has 21 references indexed in Scilit:
- Botulinum toxin A (Botox®) and sweating-dose efficacy and comparison to other BoNT preparationsAutonomic Neuroscience, 2005
- Botulinum Toxin Type B Blocks Sudomotor Function Effectively: A 6 Month Follow UpJournal of Investigative Dermatology, 2003
- Carnitine transport: Pathophysiology and metabolism of known molecular defectsJournal of Inherited Metabolic Disease, 2003
- Increased acetylcholine levels in skin biopsies of patients with atopic dermatitisLife Sciences, 2003
- Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skinZeitschrift für Neurologie, 2003
- Release of non‐neuronal acetylcholine from the isolated human placenta is mediated by organic cation transportersBritish Journal of Pharmacology, 2001
- THE CHOLINERGIC ‘PITFALL’: ACETYLCHOLINE, A UNIVERSAL CELL MOLECULE IN BIOLOGICAL SYSTEMS, INCLUDING HUMANSClinical and Experimental Pharmacology and Physiology, 1999
- Human Keratinocytes Synthesize, Secrete, and Degrade AcetylcholineJournal of Investigative Dermatology, 1993
- The effects of botulinum toxin on the synthesis, storage and release of acetylcholineProgress in Neurobiology, 1980
- Ein neues Verfahren zu der klinischen Untersuchung der SchweißabsonderungZeitschrift für Neurologie, 1928